The Score: Constellation, Chevron, Lockheed Martin and More Stocks That Defined the Week -- WSJ

Dow Jones
01/10

By Francesca Fontana

The Score is a weekly review of the biggest stock moves and the news that drove them.

Constellation Brands

Falling beer sales didn't stop Constellation shares from bubbling higher Tuesday.

The Modelo and Corona importer reported lower quarterly sales and profit as customers, particularly Hispanic consumers, continue to buy less beer.

Constellation cited weak consumer sentiment and rising unemployment rates, as well as a downturn in "4,000-calorie jobs," or physically demanding jobs such as construction, that typically boost beer sales.

However, Constellation's results beat Wall Street's expectations. Adjusted earnings came in at $3.06 a share, while analysts expected $2.63 a share, according to FactSet.

Constellation shares rose 5.3% Thursday.

JPMorgan Chase

JPMorgan Chase is taking over the Apple credit-card program from Goldman Sachs.

The biggest bank in the country will become the new issuer of the tech giant's credit card, one of the largest co-branded programs with some $20 billion in balances. After more than a year of negotiations, the companies announced the deal Wednesday, confirming an earlier report by The Wall Street Journal.

The deal marks the end of Goldman's failed foray into consumer lending, which began with the launch of the Apple card in 2019.

Mastercard will remain the network on the card, and the banks said the transition from Goldman is expected to take about two years.

JPMorgan shares fell 2.3% Wednesday.

Paramount Skydance

Warner Bros. Discovery recommended its shareholders reject Paramount's amended hostile bid for the company, saying its existing deal with Netflix is stronger.

Paramount recently made changes to its $77.9 billion all-cash bid for the entire company, hoping it would prompt Warner to walk away from its $72 billion deal with Netflix.

But in a letter to shareholders made public Wednesday, Warner said the amended offer wasn't superior, "or even comparable," to the Netflix deal for its movie and TV studios and the HBO Max streaming service.

Paramount shares declined 1% Wednesday.

Chevron

U.S. oil stocks soared after President Trump promised to overhaul Venezuela's energy infrastructure and revive its key industry.

Among the big gainers was Chevron, which jumped 5.1% Monday. The company is the sole remaining U.S. oil major in Venezuela. Oil-field services companies such as SLB, Halliburton and Baker Hughes also rose.

But some stocks gave up their gains as details of the administration's plan emerged, including Trump's goal for oil prices to fall to $50 a barrel. Many companies see that price as the threshold where it becomes unprofitable to drill, and a sustained period of low oil prices could decimate the U.S. shale industry, which has been a key backer of the president.

A plan under consideration envisions the U.S. exerting some control over Venezuela's state-run oil company Petróleos de Venezuela SA, or PdVSA, including acquiring and marketing the bulk of the company's oil production, The Wall Street Journal reported Wednesday.

Ventyx Biosciences

Eli Lilly agreed to pay around $1 billion for drugmaker Ventyx Biosciences, a deal that could help Lilly compete in a promising new area of autoimmune treatment.

Lilly announced the deal Wednesday, confirming an earlier report by The Wall Street Journal.

Ventyx has been developing autoimmune treatments targeting a complex of proteins, called NLRP3, that researchers have found plays an important role in the body's inflammatory response. The space is promising for drug giants, such as Lilly and rivals Roche and Novo Nordisk. Roche and Novo have been circling the emerging category, according to Jefferies analysts.

If Ventyx's experimental pills pan out, they would add to Lilly's portfolio of treatments for autoimmune conditions, as well as for obesity and related disorders.

Ventyx shares soared 37% Wednesday.

Lockheed Martin

President Trump's call for a bigger defense budget sparked a rally in Lockheed Martin and other U.S. weapons makers.

President Trump called for a $1.5 trillion defense budget, about $500 billion more than the Pentagon is expected to receive this fiscal year. In a social-media post late Wednesday, Trump said the increased budget was necessary "especially in these very troubled and dangerous times."

Lockheed Martin said it would more than triple PAC-3 missile production after reaching a seven-year deal with the Pentagon.

Lockheed Martin shares gained 4.3% Thursday.

Our weekly markets news roundup is now part of the WSJ's What's News podcast. Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Check out What's News in Markets at wsj.com/podcasts or wherever you listen.

Write to Francesca Fontana at francesca.fontana@wsj.com

 

(END) Dow Jones Newswires

January 09, 2026 17:19 ET (22:19 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10